Skip to content
PeptideAgent

Clinics in Illinois

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Illinois law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Illinois at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Illinois

No verified clinics serving Illinois are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Illinois

Yes. An Illinois resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Illinois-licensed provider, including by telehealth under the Illinois Telehealth Act (225 ILCS 150), which requires any professional treating a patient located in Illinois to be licensed or authorized in Illinois and to meet the in-person standard of care. Compounded peptides are available when eligible under federal 503A rules and dispensed by an Illinois pharmacy or a nonresident pharmacy licensed by the Illinois Department of Financial and Professional Regulation under the Pharmacy Practice Act (225 ILCS 85/16a). [1] [2] [3] [4] [5] [6] [9]

Compounded GLP-1 access in Illinois

Illinois patients using telehealth GLP-1 programs should confirm the prescriber holds an Illinois license and that the dispensing pharmacy holds an IDFPR nonresident pharmacy license. IDFPR has not issued its own GLP-1 rule, but it relays federal positions to licensees: its Pharmacy page posts FDA's July 2024 letter on adverse events with compounded semaglutide and tirzepatide, and its Spring 2025 compliance newsletter restated FDA's timelines that ended 503A enforcement discretion for compounded tirzepatide and set April 22, 2025 for semaglutide. [1] [2] [4] [8] [10]

Research use only sellers in Illinois

Only IDFPR-licensed pharmacies, including licensed nonresident pharmacies, may dispense prescription drugs to Illinois patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. The Illinois Food, Drug and Cosmetic Act, 410 ILCS 620/17, separately bars any person from selling, delivering, holding for sale, or giving away a new drug unless an application for it has been approved under section 505 of the federal act, and 68 Ill. Adm. Code 1330.30(j) makes dispensing a drug that is not FDA approved, not in the USP-NF, and not on the FDA bulks list unprofessional conduct for a licensee. [4] [5] [7] [11]

Illinois notes on specific peptides

  • Semaglutide: Available branded by prescription from an Illinois-licensed provider, including by telehealth under 225 ILCS 150. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [10]

How to check a clinic in Illinois

  1. Confirm the prescribing clinician's license with the Illinois medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Illinois State Board of Pharmacy (Illinois Department of Financial and Professional Regulation) license lookup. [1] [4] [5] [9]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Illinois. [4] [5] [7] [11]

Common questions in Illinois

Can I get a GLP-1 prescription through telehealth in Illinois?

Yes, from a provider licensed or authorized to practice in Illinois. The Illinois Telehealth Act lets licensed professionals practice by telehealth within their scope of practice, held to the same standard of care as in-person visits. [2]

Can a doctor licensed only in another state prescribe to me in Illinois?

Generally no. The Telehealth Act requires a professional treating a patient located in Illinois to be licensed or authorized in Illinois, and section 49.5 of the Medical Practice Act requires physicians practicing telemedicine with Illinois patients to hold an Illinois license. [2] [3]

All peptide legal questions for Illinois

Sources

  1. [1]Illinois Department of Financial and Professional Regulation: Pharmacy (State Board of Pharmacy)
  2. [2]Illinois Telehealth Act, 225 ILCS 150
  3. [3]Illinois Medical Practice Act, 225 ILCS 60/49.5, Telemedicine
  4. [4]Illinois Pharmacy Practice Act, 225 ILCS 85/16a, Nonresident pharmacies
  5. [5]68 Illinois Administrative Code Part 1330, Pharmacy Practice Act rules (including sections 1330.30 and 1330.640)
  6. [6]Illinois Telehealth Act, 225 ILCS 150, sections 5, 10, and 15 (Illinois General Assembly)
  7. [7]Illinois Food, Drug and Cosmetic Act, 410 ILCS 620/17, New drugs (Illinois General Assembly)
  8. [8]IDFPR Compliance Capsule, Spring 2025 (semaglutide and tirzepatide compounding updates)
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts